20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is AMOXICILLIN USP, with a corresponding US DMF Number 18816.
Remarkably, this DMF maintains an Active status since its submission on August 31, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 31, 2013, and payment made on July 19, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II